Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas

Published:2009-09 Issue:3 Volume:55 Page:346-352
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Fernandes Raquel C M,Bevilacqua Jose L B,Soares Ibere C,Siqueira Sheila A C,Pires Luis,Hegg Roberto,Carvalho Filomena M

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2009.03380.x/fullpdf

Reference25 articles.

1. Meeting highlights: international expert consensus on the primary therapy of early breast cancer;Goldhirsch;Ann. Oncol.,2005

2. Molecular portraits of human breast tumours;Perou;Nature,2000

3. Predicting the clinical status of human breast cancer by using gene expression profiles;West;Proc. Natl Acad. Sci. USA,2001

4. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications;Sorlie;Proc. Natl Acad. Sci. USA,2001

5. Breast cancer classification and prognosis based on gene expression profiles from a population-based study;Sotiriou;Proc. Natl Acad. Sci. USA,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Basis of Breast Cancer;Modern Breast Cancer Imaging;2021-11-01

2. Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines;Oncology Letters;2018-11-26

3. Expression of Breast Cancer Subtypes Based on the Most Important Biomarkers: Comparison of Clinicopathological Factors and Survival;Iranian Red Crescent Medical Journal;2018-01-10

4. PREVALENCE OF MOLECULAR SUBTYPES OF CARCINOMA OF BREAST- A STUDY FROM NORTH INDIA;Journal of Evolution of Medical and Dental Sciences;2017-11-13

5. Bim may be a poor prognostic biomarker in breast cancer patients especially in those with luminal A tumors;Cancer Biomarkers;2017-07-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3